282 related articles for article (PubMed ID: 18794388)
1. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL
Circulation; 2008 Sep; 118(14):1467-75. PubMed ID: 18794388
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):24-30. PubMed ID: 19834103
[TBL] [Abstract][Full Text] [Related]
3. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
Flowers MT; Miyazaki M; Liu X; Ntambi JM
J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
[TBL] [Abstract][Full Text] [Related]
4. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.
MacDonald ML; van Eck M; Hildebrand RB; Wong BW; Bissada N; Ruddle P; Kontush A; Hussein H; Pouladi MA; Chapman MJ; Fievet C; van Berkel TJ; Staels B; McManus BM; Hayden MR
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):341-7. PubMed ID: 19095997
[TBL] [Abstract][Full Text] [Related]
5. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
6. Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice.
Mukherjee P; Hough G; Chattopadhyay A; Grijalva V; O'Connor EI; Meriwether D; Wagner A; Ntambi JM; Navab M; Reddy ST; Fogelman AM
J Lipid Res; 2018 Oct; 59(10):1818-1840. PubMed ID: 30139760
[TBL] [Abstract][Full Text] [Related]
7. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
8. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation.
Sampath H; Ntambi JM
Ann N Y Acad Sci; 2011 Dec; 1243():47-53. PubMed ID: 22211892
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
10. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.
MacDonald ML; Singaraja RR; Bissada N; Ruddle P; Watts R; Karasinska JM; Gibson WT; Fievet C; Vance JE; Staels B; Hayden MR
J Lipid Res; 2008 Jan; 49(1):217-29. PubMed ID: 17960025
[TBL] [Abstract][Full Text] [Related]
11. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ
Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839
[TBL] [Abstract][Full Text] [Related]
12. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
Flowers MT; Ntambi JM
Curr Opin Lipidol; 2008 Jun; 19(3):248-56. PubMed ID: 18460915
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
14. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.
Brown JM; Rudel LL
Curr Opin Lipidol; 2010 Jun; 21(3):192-7. PubMed ID: 20216310
[TBL] [Abstract][Full Text] [Related]
16. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo.
Peter A; Weigert C; Staiger H; Machicao F; Schick F; Machann J; Stefan N; Thamer C; Häring HU; Schleicher E
Diabetes; 2009 Aug; 58(8):1757-65. PubMed ID: 19478146
[TBL] [Abstract][Full Text] [Related]
17. Metabonomic Changes Associated with Atherosclerosis Progression for LDLR(-/-) Mice.
Li D; Zhang L; Dong F; Liu Y; Li N; Li H; Lei H; Hao F; Wang Y; Zhu Y; Tang H
J Proteome Res; 2015 May; 14(5):2237-54. PubMed ID: 25784267
[TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
[TBL] [Abstract][Full Text] [Related]
19. Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions.
Qiang L; Kon N; Zhao W; Jiang L; Knight CM; Welch C; Pajvani U; Gu W; Accili D
Cell Rep; 2015 Jun; 11(11):1797-808. PubMed ID: 26074075
[TBL] [Abstract][Full Text] [Related]
20. Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes.
Matsui H; Yokoyama T; Sekiguchi K; Iijima D; Sunaga H; Maniwa M; Ueno M; Iso T; Arai M; Kurabayashi M
PLoS One; 2012; 7(3):e33283. PubMed ID: 22413010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
